Merz Aesthetics Sponsors Symposium Highlighting Market Trends With a Portfolio Approach at the 2025 Aesthetic and Anti-aging Medicine World Congress (AMWC)

24.3.2025 08:00:00 CET | Business Wire | Press Release

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, is set to unveil new data on its product portfolio and offer insights into the latest trends in the industry at the 2025 Aesthetic and Anti-Aging Medicine World Congress held in Monaco, France.

“Thanks to the scientific profile of our products, our portfolio continues to meet evolving expectations of physicians,” said Dr. Kerstin Olsson, Head of Medical Affairs in EMEA, “from routine procedures to cutting-edge treatments, we’re redefining innovation in the aesthetics industry”.

“We recognize that beauty is personal and unique to everyone. We are dedicated to understanding the needs of health care professionals and their patients,” said Gonzalo Mibelli, President, EMEA, Merz Aesthetics. “We look forward to sharing our latest data and vision for the future of medical aesthetics”.

Merz Aesthetics’ programming includes a sponsored symposium on March 28 from 14:00 - 16:00, The Evolution of Aesthetics: Foundations, Trends and Future, moderated by Dr. Mariana Muniz, featuring commentary from Dr. Martina Kerscher, Dr. Kate Goldie, Dr. Jani van Loghem, Dr. Nabil Fakih and Dr. Jonathan Kadouch. During the session, the group of experts will highlight emerging trends in medical aesthetics and demonstrate how solutions are tailored for personalized treatments.

In addition to the symposium, Merz Aesthetics is presenting six talks under the umbrella of MAX Merz Aesthetics Exchange, which are taking place at the booth P1, Level 1:

The Science of Connection: Using Synchrony to Improve Patient Communication; Joshua Bernstein, Neuroconsultant; Thursday, March 27; 13:15
Unlock your Social Media: Insights from a leading expert; Dr. Emi Arpa; Thursday, March 27; 13:45
Enhancing Lips: Tailored techniques based on age & gender; Dr. Awat Hassan; Thursday, March 27; 16:15
Mastering the Patient Journey; Vanessa Bird, Business Expert; Friday, March 28; 10:45
Radiesse: Unlock the Secret to a youthful-looking & smoother Décolleté; Dr. Rosalia Luketina; Friday, March 28; 13:15
Radiesse – Biostimulatory Scaffold in Regenerative Aesthetics – Nonclinical research; Dr. Ewelina Kaczuba; Dr. Yoana Dimitrova; Saturday, March 29; 10:45

Twenty e-posters will be available for viewing on-site throughout the congress and displayed on the virtual e-poster platform with detailed abstracts. They include:

Efficacy and Safety of IncobotulinumtoxinA in the treatment of Upper Facial Lines: Findings from two phase III randomized, double-blind, placebo-controlled studies - Tatjana Pavicic MD, Michael Gold MD, Martina Kerscher MD, Vladimir Sudimac MD, Petra Weissenberger MD, John Joseph MD
Long-term Durability of IncobotulinumtoxinA Treatment in the Upper Face as Reported by Global Aesthetic Improvement Scale - Michael H. Gold, MD; Andy Curry, PhD; Ivanti Galloway; Z. Paul Lorenc M.D., F.A.C.S.
Lifting and Structural Enhancement of Dermal Fillers with Cohesive Polydensified Matrix® Technology - Pia Vestweber, PhD; Yoana Dimitrova, MSc; Kay Marquardt, PhD; Thomas Hengl, PhD
Long-Term Skin Improvement through Combined MFU-V and CaHA Treatments - Tingsong Lim, MD; Meng Jun Ho, MD
The Cohesive Polydensified Matrix Hyaluronic Acid (CPM-HA) Gels Demonstrate Biomimetic Tissue Plane Adaptation: An Integrative Analysis of Physiochemical Properties - Gabriela Casabona, MD; Radovan Vukicevic, PhD; Angela Prager, PhD; Mimi R. Borrelli, MBBS, PhD, MSc

About Merz Aesthetics

Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically proven, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient’s needs with high standards of safety and efficacy. Being family owned for more than 115 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics’ global headquarters is in Raleigh, N.C., USA, with a commercial presence in 90 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more at merzaesthetics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250324799451/en/

Contacts

Media Contact
Diana Trojanus - EMEA Communications - Merz Aesthetics GmbH - Eckenheimer
Landstraße 100, 60318 Frankfurt am Main, Germany, Media@merz.com

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Clearwater Analytics Finalizes Acquisition of Enfusion21.4.2025 22:15:00 CEST | Press Release

Clearwater Analytics (NYSE: CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE: ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry’s first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management, IBOR, risk, accounting, and client reporting into one seamless solution, Clearwater is replacing the fragmented legacy model with a modern platform that empowers faster decision-making and operational clarity across asset classes and geographies. “The close of the Enfusion acquisition marks a major milestone—not just for Clearwater, but for the entire investment management industry,” said Sandeep Sahai, Chief E

Estithmar Holding Reports an Exceptional 50% Surge in Net Profit to QAR 170 Million21.4.2025 21:03:00 CEST | Press Release

Estithmar Holding Q.P.S.C. announced a net profit of QAR 170 million for Q1 2025, reflecting a 50% increase compared to the same period last year. The company highlighted a 64% surge in revenue, reaching QAR 1.3 billion compared to QAR 797 million in Q1 2024. Gross profit rose to QAR 416 million, from QAR 196 million in Q1 2024. EBITDA reached QAR 273 million, marking a 53% increase. Earnings per share also grew by 57%, reaching QAR 0.047. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250421669945/en/ Estithmar Holding Reports an Exceptional 50% Surge in Net Profit to QAR 170 Million (Infographic: AETOSWire) These strong financial indicators reflect the efficiency of Estithmar Holding’s investment strategy. International projects previously announced by Estithmar Holding started to have a tangible impact on its financial performance in revenue, profits and assets. The results reflect the achievement of a strategic objective

Leading Global Battery Expert Kenneth Hoffman to Join Pure Lithium as Special Advisor21.4.2025 16:52:00 CEST | Press Release

Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announces that Kenneth Hoffman (CFA, CIM) will join the company as a Special Advisor, leveraging his vast experience across the battery value chain to advance our drive towards full commercialization. Mr. Hoffman, who was previously Global Head of Battery Materials at McKinsey, will be a crucial asset for Pure Lithium’s commercialization strategy and development of partnerships. Working directly with Pure Lithium CEO Emilie Bodoin, he will bring a deep understanding of batteries and a unique ability to connect market dynamics with operational decision making that will be invaluable for Pure Lithium. Pure Lithium Founder and CEO Emilie Bodoin said: “I feel very privileged to bring Ken aboard at this crucial time in Pure Lithium’s evolution. He is simply one of the leading experts on batteries, forming partnerships and developing successful businesses in energy storage. We

China’s Moutai Elevates Chinese Liquor Culture onto the Global Stage21.4.2025 15:59:00 CEST | Press Release

China’s premier liquor brand Moutai captivated audiences with an impressive exhibition highlighting its global journey and the richness of Chinese liquor culture at the recently concluded 5th China International Consumer Products Expo (CICPE), or Hainan Expo 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250421891944/en/ Moutai’s pavilion at the recently concluded 5th China International Consumer Products Expo in Haikou, China. Held in Haikou, the capital of South China's Hainan Province, the five-day event welcomed over 1,700 enterprises and 4,200 consumer brands from 71 countries and regions. From technology and jewelry to gourmet food and Chinese lifestyle products, the Expo served as a vibrant showcase of global consumer trends. On this international stage, Moutai stood out as a symbol of Eastern elegance. Under the theme “Share Open Opportunities, Co-create a Better Life,” the brand spotlighted the cultural signif

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights21.4.2025 14:05:00 CEST | Press Release

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development, has released an in-depth report on the global clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF). The report offers strategic insights and comprehensive analysis critical for biotech and pharmaceutical companies navigating the complexities of IPF clinical research and drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250421636360/en/ Advancing IPF Clinical Research: A Global Perspective Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease characterized by the scarring of lung tissue and a steady decline in respiratory function, most commonly affecting individuals between the ages of 60 and 70. Novotech’s latest report identifies more than 800 industry-sponsored IPF c

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom